The stock's rise snapped a three-day losing streak.

The combination of Henry Schein’s distribution capabilities with Acentus’ technology expertise will pack a one-two punch as ...

Equities research analysts at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Henry Schein in a research note issued to investors on Tuesday, March 11th. William ...

Shares of Henry Schein Inc. HSIC slipped 4.09% to $69.94 Wednesday, on what proved to be an all-around mixed trading session ...

Henry Schein is supporting the Special Olympics Healthy Athletes screenings at the Special Olympics World Winter Games March 8-15, 2025, in Turin, Italy, by donating a range of oral ...

Highlights,Charles Schwab Investment Management increased its holdings in Henry Schein, reaching close to 1% ownership.,Institutional investors actively adjusted their positions, reflecting evolving ...

Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage biopharmaceutical company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that ...

Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical ...

Henry Schein has been outperforming the S&P 500 since December 2024. Check out the price action, momentum, volume, and ...

Learn more about whether Henry Schein, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...

Rating, from 69 to 74. Please watch the video at Investors.com - How To Find The Best IPO Stocks IBD's unique rating tracks ...

Meeting to be held on March 10 at 11 am hosted by Oppenheimer. Discover the Best Stocks and Maximize Your Portfolio: See what stocks are ...